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Summary. The response of an experimental sarcoma to single doses and two
fractions of x-rays and fast neutrons has been investigated to test the hypothesis that
slowly shrinking sarcomata will reoxygenate poorly and therefore will benefit
more from fractionated neutron treatment than from fractionated x-ray treatment,
in contrast with rapidly shrinking carcinomata. Neutrons were approximately
three times more effective than x-rays, both for single doses and for two fractions
given in 48 hours, when regrowth was used as a measure of response. This observa-
tion is closely similar to results previously obtained on a rat fibrosarcoma and
contrasts with previous results from a mouse mammary carcinoma, and is in
agreement with the hypothesis.
MOST animal solid tumours have been
found to contain hypoxic cells (e.g. Thom-
linson, 1960; Hewitt, Chan and Blake,
1967; Van Putten and Kallman, 1968)
and single doses of neutrons have been
found to be more effective in damaging
such tumours, relative to theeffect on nor-
mal tissues, than single doses of x or y rays
(e.g. Field, Jones and Thomlinson, 1967;
Barendsen and Broerse, 1969; Fowler et
al., 1972). However, a natural process of
reoxygenation of these hypoxic cells may
occur in the intervals between doses if a
fractionated course of irradiation is given
(Thomlinson, 1968). In such circum-
stances neutrons would be expected to
lose some, or even all, of their advantage
over x-ray treatment. It has been postu-
lated on the basis of the proliferation
kinetics and the initial response to irradi-
ation (Denekamp, 1968, 1972) that animal
sarcomata which do not shrink rapidly
after large doses of radiation will not
reoxygenate extensively and therefore
will benefit from a treatment such as
neutron therapy, whereas rapidly shrink-
ing experimental carcinomata may over-
come their hypoxic cell problem by an
efficient natural process of reoxygenation.
A loss of therapeutic gain with neutrons
has been observed in fractionated experi-
ments on a mouse mammary carcinoma
(Fowler et al., 1972) which was known to
reoxygenate extensively (Howes, 1969);
however, in a rat fibrosarcoma with less
reoxygenation(Thomlinson, 1968)neutrons
were found to be more effective than
x-rays even if a fractionated regimen was
used (Field, Jones and Thomlinson, 1968).
The effect ofsingle doses and two fractions
ofx-rays and neutrons was therefore tested
on another rapidly growing fibrosarcoma.
MATERIALS AND METHODS
The CBA sarcoma used in the present
experiments (Sarcoma F) was obtained from
Hewitt, who has previously described its
origin and its use in various radiobiological
studies involving measurements of cell sur-
vival (Hewitt and Wilson, 1961; Hewitt,
1966). The tumour was transplanted subcu-
taneously on the ventral wall of the thorax of
3-month old male mice. The growth of the
tumours was recorded by measuring 3
perpendicular diameters. Tumours were
selected for irradiation when they reached a
mean diameter of between 7-5 and 10 mm,RESPONSE OF A MOUSE SARCOMA
at which size they had a volume doubling
time of one day and virtually no cell loss
(Begg, personal communication). They were
then irradiated with single doses of 250
kV x-rays or cyclotron neutrons, or with 2
equal fractions separated by an interval of
2 days. The x-rays were generated from a
250kVp Maximar x-ray set, filtered with
0-25 mm Cu, 1 0 mm Al, giving a h.v.l. of
1-3 mm Cu, and delivered at a dose rate of
180 rad/min through portals 1-5 x3 cm in
size. Two tumours were x-irradiated simul-
taneously, being turned through 180° and
changed from one portal to the other after
half the dose had been given, to minimize
dose non-uniformity. The fast neutrons
were produced by 16 MeV deuteron bombard-
ment of the beryllium target in the MRC
cyclotron; the target to skin distance was
100 cm and the dose rate was 40-80 rad/min
through holes 2-5 cm in diameter. Five
tumours could be irradiated simultaneously
and these were also turned through 1800
and changed from hole to hole to improve
dose uniformity. The animals were anaes-
thetized with Nembutal (60 mg/kg body
weight) before irradiation and were breathing
oxygenflowing at 6 1/min, warmedto 25+ 1°C,
except for one x-ray experiment where they
were irradiated in air at room temperature.
After irradiation the tumours were measured
5 times a week until they reached a mean
diameter of 16 mm, when the animals were
sacrificed. Growth curves were constructed
byplottingthe average valueforthegeometric
mean diameters of the tumours of a group of
mice given the same treatment. Dose
response curves were then constructed by
determining (a) the time taken for regrowth
to a given size (e.g. 10 mm mean diameter,
i.e. approximately 500 mm3), or (b) by taking
the area between the growth curve and some
arbitrary upper size limit, e.g. 12 mm.
Method (b) is new and is believed to represent
more closely the volume reduction of the
tumour, since it uses all the measurements,
including both the minimum size estimate
and the rate of regrowth to the arbitrarily
chosen limit.
RESULTS
Some ofthe growth curves for tumours
given different treatments are shown in
Fig. la (single doses) and Fig. lb (2 frac-
tions). The error bars shown on the
22
neutron curves are the standard errors of
the mean for each group of animals and
these represent the variability in response
of different animals given the same treat-
ment. It is apparent from Fig. la that
single doses ofneutrons are approximately
3 times as effective as single doses of
x-rays (e.g. the curves for 4500 rad x-rays
and 1500 rad neutrons are very similar),
and there are no qualitative differences
in response. The dose effect curves
shown in Fig. 2 and 3 were derived from
such growth curves; unless stated, the
animals were irradiated breathing warm
oxygen.
Figure 2 shows the time taken to reach
a mean diameter of 10 mm for groups
given different treatments. The errors
shown were obtained by drawing an enve-
lope through the standard errors of the
mean on the growth curves and represent
approximately 70% confidence limits for
the time at which each group crossed
10 mm mean diameter. Single doses of
x-rays given in air were less effective than
single doses given to animals breathing
warm oxygen. The single dose curve for
oxygen breathing animals appears to be
biphasic with a break-point at about 3000
rad. Two fractions given 2 days apart
to animals breathing oxygen appear signi-
ficantly less effective than a single dose,
except for the highest dose. The single
dose neutron curve (to animals breathing
02) might be biphasic, although a smooth
line could be drawn through the error
bars. Two fractions of neutrons also
appear to be slightly less effective than
single doses at low dose levels but some-
what more effective at high doses.
Figure 3 shows the dose response
curves obtained by the new method of
integrating the area over each growth
curve,i.e.bysubtractingthe meandiameter
for each day from an arbitrary size of
12 mm mean diameter, and correcting for
the rather small differences in mean size
at the day of irradiation. In this way all
the growth measurements are used, rather
than the few that define the time to cross
a given arbitrary size limit, or the size
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FIG. 1.-Growth curves of the tumours after various treatments plotted as the mean diameter V8 time
after irradiation. The vertical error bars on the neutron curves are standard errors of the mean
for each group ofanimals on a particular day. (Dosage measured in rad.) (a) Single doses of x-rays
and neutrons. (b) Two fractions in 48 h of x-rays and neutrons.
on a given day. This integrated area
representsthelossoftumourvolumecaused
by the radiation and takes into account
the degree of shrinkage, the length of
time the tumour stays small and the rate
of regrowth. The curves derived from
this analysis are closely similar to those
derived from the time to regrow to 10 mm
(Fig. 2), but make use of size measure-
ments over a longer range of time so that
the confidence limits are smaller. This
method is more precise than simply using
time to regrow to a particular size, and is
recommended in preference to it. The
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FIG. 2.-Dose response curves obtained by plotting the time taken to regrow to 10 mm mean diameter
after irradiation as a function of dose.
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FIG. 3.-Dose response curves obtained by integrating the area between each tumour regrowth curve
and an upper size limit of 12 mm mean diameter (arbitrary units). This is thought to represent
more closely the volume reduction oi the tumour than simply time to regrow to a certain size as
in Fig. 2.
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similarity in the two figures is probably
because this sarcoma, like many others,
does not shrink below 4-6 mm even after
high doses. In carcinomata the smallest
volume achieved before regrowth is more
dose dependent.
The RBE values for fast neutrons and
the (D2-D1)48 h values for x-rays and
neutrons were measured from the doses to
achieve the same effect in Fig. 2 and 3.
The RBE is the ratio of x-ray and
neutron doses to produce the same effect.
(D2-D1)48 h is the dose increment needed
to produce the same level of damage when
the dose is given in two fractions D2 or
in a single dose D1. The RBE was found
to vary with the degree of damage, as has
been observed previously (Field and
Hornsey, 1971). RBE values at various
dose levels are shown in Table I; values
of 2-4-3-3 were found for single doses of
neutrons, being lowest at 1000 rad of
neutrons. Similar or slightly higher RBE
values of between 2-6 and 3-9 were found
for 2 fractions/48 h, again being lowest
for low doses. The (D2-D1)48 h for x-rays
is positive for the low doses and is negative
at higher doses (Table II). A similar
change from positive to negative occurs
with increasing doses of neutrons.
DISCUSSION
This sarcoma F was previously shown
to contain a large proportion of hypoxic
cells which were apparently inaccessible
to hyperbaric oxygen when tested for
cell survival by making a single-cell
suspension and assaying serial dilutions
TABLE I. RBE Valueo for Sarcoma F at
Different Dose Levels
Neutron dose
pet fiaction (rad)
Single doses 500
1000
1500
2000
2500
Two fractions 250
500
750
RBE fast neutrons
(a) (b)
:3 -1 3-1
2-7 2-4
:3-2 :3-2
3-3 :3 0
3 0 -
2 6 2-9
2-9 2-9
:3 7 3.9
(a) Time to regrow to 10 mm diameter.
(b) Volume redtuction calculated from integrated
area above growth curve.
in vivo (Hewitt and Wilson, 1961; Hewitt,
1966).
In the present experiment most of the
irradiations were performed on animals
breathing warm oxygen in order to com-
pare with other results (Hawkes et al.
1968; Fowler et al., 1972). A comparison
of the animals which received single doses
of x-rays breathing either oxygen or air
shows that the dose administered to
oxygen breathing animals was more effec-
tive than that given in air (Fig. 2, 3).
This is interpreted as due to improved
oxygenation of some of the hypoxic cells
in this tumour when the animals breathe
oxygen, but raises the question of why
virtually no increase in sensitivity was
observed by Hewitt (1966) when he used
3 atmospheres pressure of 02 in the
same type of tumour. It could be due to
a difference in the methods of assay in the
two sets of experiments; hypoxic cells
may be rescued from death due to hypoxia
TABLE II. Dose Increments (D2-D1) Necessary if 2 Fractions are used to Achieve
the Same Effect as a Single Dose
(D2-Dl)48 h
(a) (b)
150 50
500 1000
-500 -200
Neutron
(lose/fraction
(rad)
250
500
750
1000
(D2-Dl)48 h
(a) (b)
100 50
130 100
-130 -200
-230 -300
X-ray dose
per fraction
(rad)
750
1500
3000
(a) Time to regrow to 10 mm diameter.
(b) Volume reduction calculated from integrated area above growth curve.
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by the transplantation assay technique,
but will die if left in situ. It is possible
that in unanaesthetized mice (in Hewitt's
experiments) there is a physiological res-
ponse to hyperbaric oxygen which results
in vascular constriction and counteracts
the beneficial effects of additional 02
availability in the blood (Johnson, 1971;
Milne, Hill and Bush, 1973). This could
be absent from the present experiments
because the mice were anaesthetized with
Nembutal.
In the present experiments there was
a sparing effect of dose fractionation for
x-ray doses per fraction up to 1500 rad,
and for neutron doses per fraction up to
500 rad (Table II). At higher doses,
however, the curves in Fig. 2 and 3 cross
over, i.e. two doses are more effective than
a single dose. A similar phenomenon
after x-irradiation was also observed with
spontaneous and transplanted mammary
carcinomata (Hawkes et al., 1968) and
with the rat fibrosarcoma RIB 5 (Field
et al., 1968). The explanation given was
that reoxygenation was more than counter-
acting the effect ofrecovery from sublethal
injury in the air breathing animals, but
only at high doses. The same explanation
is suggested for the present tumour.
In spite of the probability of some
reoxygenation occurring between the frac-
tions in the present sarcoma F, the RBE
for neutrons stays high whether the dose
is administrered as one or two fractions.
For single doses the RBE is high at low
doseswheredifferences intheaccumulation
of sublethal injury predominate, falls at
intermediate dose levels (i.e. 1000 rad)
and rises again at high doses where the
hypoxic cell response plays a large part
in the response of the tumour. For two
fractions the RBE also rises at the hioher
doses, suggesting that hypoxic cells are
still important, i.e. reoxygenation, if it
occurs, is inadequate.
Table III summarizes the RBE data
for fractionated neutron irradiation of
animal tumours on the Hammersmith
cyclotron (Field et al., 1968; Fowler et al.,
1972; Fowler et al., 1974; Fowler, Dene-
kamp and Field, 1974). Since different
endpoints have been used in the three
experiments, high levels of delay in
regrowth of the sarcomata have been used
for comparison with the local control
experiments on the C3H mammary carci-
noma. However, similar RBEs have been
obtained for local control and for regrowth
(Fowler et al., 1972; Field et al., 1968).
The RBE is high for single doses to all
three tumours (3.1 for sarcoma F, 3-6 for
RIB5 and 3-3 for the mammary carci-
noma), confirming the presence ofhypoxic
cells which are resistant to x-irradiation.
With fractionation, the RBE will fall if
extensive reoxygenation occurs, but will
remain high if hypoxic cells are still a
major problem. However, at low doses
the RBE will rise again because of a
TABLE III.-RBE for Tumours Treated with Fractionated Doses of Cyclotron Neutrons,
and Therapeutic Gain Factors Relative to Skin
Tumour
(a)Sarcoma F
(b)RIB5 Sarcoma
(c)C,H Carcinoma
No. of fractioins
2
2
5
9
15
(a) :30 (lays delay in regrowth to 10 mm.
(b) 40 days delay in regrowth to 25 mm (Field, Jones and Thomlinson, 1968).
(c) Local control at 150 days (Fowler et (li., 1972 and Fowler, Denekamp and Field, 1974).
(d) RBE from ratio of x-ray and neutron doses to produce the same effect.
(e) Therapeutic gain factor is the ratio of RBE tumour to RBE skin at the same level of dose.
X-ray dose
per fraction
(rad)
3000
1800
910
1200
800
620
400
(d)RBE
3 *7
3 6
3 -2
2 -3
2 *6
3-1
3 0
(e)Therapeutic
gain factor
2 -2
2-1
1 *4
1*0
0 9
1*1
1 0
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reduced ability to accumulate sublethal
injury after neutron compared with x-
irradiation. In order to assess the relative
usefulness, a therapeutic gain factor TGF
can be calculated from the ratio of RBE
tumour to RBE normal tissue at the same
level of dose. This is also shown in Table
III; RBE values for skin have been
obtained from the curve for RBE as a
function of dose per fraction (Field and
Hornsey, 1971). The TGF values are
1 8-2 1 for single doses to these three
tumours; with fractionation the values
range from 14 to 2-2 in the sarcomata,
but fall to l 1-0 9 in the mammary
carcinoma. TGF values of unity show
that no advantage will be gained using
neutrons relative to x-rays for that type
of tumour. Although reoxygenation dif-
ferences could account for the difference
in TGF for fractionated irradiation of
carcinomata and sarcomata, differences
in inherent cell radiosensitivity cannot be
excluded.
The existing experimental data support
the view that slowly shrinking experi-
mental sarcomata may have inadequate
reoxygenation processes and should there-
fore benefit from neutron therapy during
fractionated irradiation. In rapidly
shrinking experimental carcinomata on
the other hand, although they may show
the same great advantage of neutrons
when tested with single dose experiments,
the advantage will be lost if shrinkage
occurs during the multifraction irradiation
and is accompanied by extensive reoxy-
genation, so that hypoxic cells are not a
real problem, as in the tumour described
by Fowler et al. (1972).
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